Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery
NCT: NCT05625958 · ACTIVE_NOT_RECRUITING
Реклама
NCT IDNCT05625958
СтатусACTIVE_NOT_RECRUITING
Дата начала2023-03-23
Завершение2028-09-01
Краткое описание
The purpose of this study is to evaluate the safety and effectiveness of implanting a new version of an interposition supraciliary implant (SV22) as a stand-alone therapy for lowering intraocular pressure (IOP) in patients with primary open and narrow angle glaucoma who have failed at least one class of topical medical therapy
Официальный источник
Открыть на ClinicalTrials.gov →Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.